- ACTUARIAL DATA SCIENCE
- AFIR / ERM / RISK
- ASTIN / NON-LIFE
- BANKING / FINANCE
- CORONA SPECIAL
- DIVERSITY & INCLUSION
- IACA / CONSULTING
The discussion between the panelists aim to give insight into:
-How should the industry incorporate vaccination status for covid, and any other virus, in the pricing and underwriting. How will it impact the scheme and the FCL
-How do claims teams deal with the volatility in claim numbers to ensure timely payment
-How should brokers respond to sharply increased pricing in setting benefit levels and selecting insurers
-Should we expect changes to traditional group risk products, or the discontinuance of certain products
-Do they expect that pricing will return to pre-pandemic levels
More topics will be discussed as they develop during the conversation.
There are no comments yet. Add a comment.